Advances in Pharmacoepidemiology and Drug Safety

Advances in Pharmacoepidemiology and Drug Safety
Open Access

ISSN: 2167-1052

+44 1202068036

Da-Yong Lu

Da-Yong Lu
School of Life Sciences,
Shanghai 200444

  • Editorial
    Cost-effectiveness Considerations of Individualized Cancer Chemotherapy
    Author(s): Da-Yong Lu, Ting Ren Lu and Hong-Ying WuDa-Yong Lu, Ting Ren Lu and Hong-Ying Wu

    The running cost for clinical cancer treatment has risen dramatically. It is a huge burden to government fiscal budgets and cancer patients’ medical expenditure. Previously, we often create new drug and methodology of high cost and waste human resources for development of many less effects and expensive anticancer drugs or other sophisticated methodologies. These efforts will greatly increase therapeutic costs. Now some countries, such as USA or Japan, are overburden with high expense of medical resources in human diagnosis and therapy, especially for human cancer therapy. One of the major obstacles to controlling cancer growth and metastases is the inappropriate use of anticancer drugs. Treatment using individualized cancer chemotherapy (ICC) has been attracting increasing attention and will continue to show beneficial outcomes in the future. Increasing efforts to develop ICC s.. Read More»
    DOI: 10.4172/2167-1052.1000e121

    Abstract PDF

Relevant Topics